Clinical Trial

Development and Testing of a Mobile App to Scale Delivery of Cognitive-behavioral Therapy for Avoidant/Restrictive Food Intake Disorder

Recruiting
View on ClinicalTrials.gov →
Summary
Avoidant/restrictive food intake disorder (ARFID) is a serious and impairing eating disorder - occurring in up to 4% of adults - for which most individuals do not have access to treatment. The proposed study aims to develop and test a mobile app to scale delivery of cognitive-behavioral therapy for ARFID. Knowledge gained will contribute to the development of a clinically accessible, scalable, inexpensive treatment for ARFID, a highly impairing disorder for which there are significant barriers to care access.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-25; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2026-06-15
Trial Details
NCT Number NCT06898177
Lead Sponsor Massachusetts General Hospital
Conditions Avoidant/Restrictive Food Intake Disorder (ARFID)
Enrollment 60 participants
Start Date 2026-04-13
Primary Completion 2030-04-01 (estimated)
Study Completion 2030-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-16